Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Regenerative macrophages enhance stem cell-derived β cell function and engraftment.

Science advances·2026
Same author

Human and mouse regenerative macrophages enhance beta cell survival, function, and proliferation.

Islets·2026
Same author

Islet amyloid disrupts MHC class II antigen presentation and delays autoimmune diabetes in NOD mice.

Diabetologia·2025
Same author

Insulin production is sustained during DNA damage-mediated senescence in adult human beta cells.

Diabetologia·2025
Same author

Assessment of protein synthesis rate enables metabolic profiling of resident-immune cells of the islets of Langerhans.

Frontiers in immunology·2025
Same author

α cells use both PC1/3 and PC2 to process proglucagon peptides and control insulin secretion.

Science advances·2025

Related Experiment Video

Updated: May 27, 2026

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

Improving islet engraftment by gene therapy.

Xiaojie Wang1, Mark Meloche, C Bruce Verchere

  • 1Department of Surgery, University of British Columbia, Vancouver, BC, Canada V5Z 4E3.

Journal of Transplantation
|December 2, 2011
PubMed
Summary

Islet cell transplantation shows promise for type 1 diabetes, but graft survival is limited. Genetic modification strategies targeting blood vessel formation and apoptosis inhibition can improve islet engraftment and long-term treatment outcomes.

More Related Videos

Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

Related Experiment Videos

Last Updated: May 27, 2026

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer
16:59

Neo-Islet Formation in Liver of Diabetic Mice by Helper-dependent Adenoviral Vector-Mediated Gene Transfer

Published on: October 10, 2012

Intraportal Transplantation of Pancreatic Islets in Mouse Model
09:01

Intraportal Transplantation of Pancreatic Islets in Mouse Model

Published on: May 5, 2018

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice
06:41

Minimizing Post-Infusion Portal Vein Bleeding during Intrahepatic Islet Transplantation in Mice

Published on: May 10, 2021

Area of Science:

  • Endocrinology
  • Transplantation Immunology
  • Regenerative Medicine

Background:

  • Islet cell transplantation is a leading treatment for type 1 diabetes.
  • Transplanted islets face significant challenges including apoptosis, inflammation, hypoxia, and poor revascularization, limiting long-term graft survival.

Purpose of the Study:

  • To explore genetic modification strategies to overcome barriers in islet transplantation.
  • To enhance islet engraftment and improve therapeutic outcomes for type 1 diabetes.

Main Methods:

  • Investigating genetic modification techniques for islet cells.
  • Focusing on overexpression or silencing of proteins involved in angiogenesis and apoptosis.

Main Results:

  • Genetic modification holds potential to mitigate damage during islet isolation.
  • Strategies can address inflammatory and hypoxic environments post-transplantation.
  • Improved revascularization and reduced apoptosis can enhance islet survival and function.

Conclusions:

  • Genetic modification offers a promising avenue to improve islet transplantation success rates.
  • Targeting angiogenesis and apoptosis is crucial for successful islet engraftment and long-term type 1 diabetes management.